Covid and commercial research decline

Inevitably, the rapid spread of an emergent and potentially lethal virus around the world has led to huge disruption of normal life. With talk of a new-normal in the wake of the COVID-19 pandemic, we do not yet have any way ...

Platform turbo-boosts development of new antibiotics

Harmful bacteria react less and less to common antibiotics. The infections they cause are therefore increasingly deadly. World health therefore urgently needs alternative antibacterial agents. "Our VersaTile platform gives ...

Pharma's potential impact on water quality

When people take medications, these drugs and their metabolites can be excreted and make their way to wastewater treatment plants. From there, the compounds can end up in waterways. Wastewater from pharmaceutical companies ...

An intelligent and compact particle analyzer

In many industrial and environmental applications, determining the size and distribution of microscopic particles is essential. For example, in the pharmaceutical industry, inline measurement and control of particles containing ...

3-D printing with applications in the pharmaceutical industry

University of Seville researchers, in collaboration with the University of Nottingham, have managed to create the first image of nanoparticles of stabilised gold with biodegradable and biocompatible systems that have been ...

New NMR approach for studying droplet-shaped cell content

Researchers in Utrecht have found a new way to observe membraneless compartments at an unprecedented level of resolution. The existence of these so-called biomolecular condensates in the cell contradicts every textbook on ...

page 9 from 17